AbbVie: Bernstein raises target price to $275 from $230
ABBV•Bernstein raised its target price for AbbVie to $275 from $230.
Related News
Sunshine Silver joins Solactive Global Silver Miners Index
SSMR•
Broadridge partners with NYSE on tokenized securities platform
BR•
Ryanair CEO expects to hedge 50% of next year's fuel, willing to take risk on remainder
RYAAY•
Public Storage: BofA Global Research raises price objective to $348 from $341
PSA•
ATS to host second-quarter earnings call
ATS•